A multivariate analysis of prognostic factors for melanoma patients with lesions greater than or equal to 3.65 mm in thickness. The importance of revealing alternative Cox models

scientific article published in January 1982

A multivariate analysis of prognostic factors for melanoma patients with lesions greater than or equal to 3.65 mm in thickness. The importance of revealing alternative Cox models is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1097/00000658-198201001-00007
P932PMC publication ID1352402
P698PubMed publication ID7055383

P2093author name stringM C Mihm
D F Roses
A B Cosimi
M N Harris
R A Malt
A W Kopf
R J Friedman
W C Wood
R A Lew
A J Sober
S L Gumport
T B Fitzpatrick
A Postel
C L Day
D Rigel
F Gorstein
F M Golomb
J W Raker
M M Mintzis
P Hennessey
T J Harrist
R W Grier
P2860cites workThickness, cross-sectional areas and depth of invasion in the prognosis of cutaneous melanomaQ24540048
The histogenesis and biologic behavior of primary human malignant melanomas of the skinQ34054176
Malignant melanoma. Prognostic significance of "microscopic satellites" in the reticular dermis and subcutaneous fat.Q36657059
Tumor thickness as a guide to surgical management of clinical stage I melanoma patientsQ41486624
A multifactorial analysis of melanoma. II. Prognostic factors in patients with stage I (localized) melanomaQ41711591
The regressing thin malignant melanoma: a distinctive lesion with metastatic potentialQ43877987
Prognostic factors in cutaneous malignant melanoma in stage I. A clinical, morphological and multivariate analysisQ44397348
A multifactorial analysis of melanoma: prognostic histopathological features comparing Clark's and Breslow's staging methodsQ52437315
Prognostic factors for patients with clinical stage I melanoma of intermediate thickness (1.51 - 3.39 mm). A conceptual model for tumor growth and metastasis.Q52730145
The Natural Break Points for Primary-Tumor Thickness in Clinical Stage I MelanomaQ52732552
A prognostic model for clinical stage I melanoma of the trunk. Location near the midline is not an independent risk factor for recurrent disease.Q52735595
Malignant melanoma of the extremities: A clinicopathologic study using levels of invasion (microstage)Q66908743
Stage I melanoma of the limbs. Immediate versus delayed node dissectionQ67250734
The spaghetti theory of leadership (and other saucy ideas)Q68318462
Prognostic factors for melanoma patients with lesions 0.76 - 1.69 mm in thickness. An appraisal of "thin" level IV lesionsQ70269701
A multifactorial analysis of melanoma: III. Prognostic factors in melanoma patients with lymph node metastases (stage II)Q70717837
A prognostic model for clinical stage I melanoma of the upper extremity. The importance of anatomic subsites in predicting recurrent diseaseQ70717847
A prognostic model for clinical stage I melanoma of the lower extremity. Location on foot as independent risk factor for recurrent diseaseQ70743908
Malignant melanoma patients with positive nodes and relatively good prognoses: Microstaging retains prognostic significance in clinical stage I melanoma patients with metastases to regional nodesQ70755933
A GENERALIZED WILCOXON TEST FOR COMPARING ARBITRARILY SINGLY-CENSORED SAMPLESQ78539166
P433issue1
P407language of work or nameEnglishQ1860
P921main subjectmultivariate statisticsQ1952580
P304page(s)44-49
P577publication date1982-01-01
P1433published inAnnals of SurgeryQ4767866
P1476titleA multivariate analysis of prognostic factors for melanoma patients with lesions greater than or equal to 3.65 mm in thickness. The importance of revealing alternative Cox models
P478volume195

Reverse relations

cites work (P2860)
Q70299689An evaluation of vertical growth in thin superficial spreading melanomas by sequential serial microscopic sections
Q50854697Analysis of histopathological factors associated with prolonged survival of 10 years or more for patients with thick melanomas (> 5 mm).
Q40347714Classification of malignant melanomas according to the histologic morphology of melanoma nodules
Q39736224Cutaneous malignant melanoma in the older patient.
Q67487509Dominant rearrangements among human tumor-infiltrating lymphocytes. Analysis of T-cells derived from 32 patients with melanoma, lung, and renal cell carcinoma
Q40717524Elective lymph node dissection for melanoma
Q72528647Failure of FAB classification to predict relapse-free survival in acute leukemia
Q39477930Immunology and immunotherapy of human malignant melanoma.
Q69597256Lymphadenectomy in the management of stage I malignant melanoma: a prospective randomized study
Q52871928Malignant melanoma prognostic factors 7: elective lymph node dissection.
Q44646044Melanoma of palms, soles, and nail-beds
Q51193234One-year follow-up of panic disorder. Outcome and prognostic factors.
Q34446288Overview analysis of adjuvant therapies for melanoma--a special reference to results from vaccinia melanoma oncolysate adjuvant therapy trials
Q71931085Pathology of malignant melanoma
Q71767718Predictors of late deaths among patients with clinical stage I melanoma who have not had bony or visceral metastases within the first 5 years after diagnosis
Q40151405Primary cutaneous malignant melanoma
Q52568001Prognostic Significance of DNA Aneuploidy in Stage I Cutaneous Melanoma
Q34964449Prognostic factors
Q55042733Prognostic factors for metastasis in cutaneous melanoma.
Q52730145Prognostic factors for patients with clinical stage I melanoma of intermediate thickness (1.51 - 3.39 mm). A conceptual model for tumor growth and metastasis.
Q35105671Prognostic factors in primary cutaneous melanoma
Q36381934Prognosticators of melanoma, the melanoma report, and the sentinel lymph node
Q26799073Reflections on the Histopathology of Tumor-Infiltrating Lymphocytes in Melanoma and the Host Immune Response
Q71688574Regression in malignant melanoma
Q47744033Sentinel Lymph Node Status is a Main Prognostic Parameter Needful for the Correct Staging of Patients with Melanoma Thicker than 4 mm: Single-Institution Experience and Literature Meta-Analysis
Q55476901Studies of the mechanism of cytolysis by tumour-infiltrating lymphocytes.
Q72528649Subsite concept for metastases in clinical stage I melanoma
Q39726052The clinical recognition and prognostic factors of primary cutaneous malignant melanoma
Q40233231The extent of primary melanoma excision. A re-evaluation--how wide is wide?
Q45411290The highly attenuated vaccinia virus strain modified virus Ankara induces apoptosis in melanoma cells and allows bystander dendritic cells to generate a potent anti-tumoral immunity
Q70454401The incidental malignant melanoma
Q70454611The incidental malignant melanoma
Q41903179The prognosis of primary and metastasising melanoma. An evaluation of the TNM classification in 2,495 patients

Search more.